ASSET | DATE | % RETURN |
---|---|---|
Soleno Therapeutics (SLNO) | 7/21/2023 - 1/10/2024 | 718.34% |
QXO (QXO) | 7/21/2023 - 1/10/2024 | 425.04% |
Cytokinetics (CYTK) | 7/21/2023 - 1/10/2024 | 213.09% |
Abercrombie & Fitch (ANF) | 7/21/2023 - 1/10/2024 | 164.45% |
Affirm (AFRM) | 7/21/2023 - 1/10/2024 | 151.07% |
Rhythm Pharmaceuticals (RYTM) | 7/21/2023 - 1/10/2024 | 143.47% |
Scholar Rock (SRRK) | 7/21/2023 - 1/10/2024 | 135.46% |
Gap (GAP) | 7/21/2023 - 1/10/2024 | 135.35% |
United States Cellular (USM) | 7/21/2023 - 1/10/2024 | 129.78% |
Telephone and Data Systems (TDS) | 7/21/2023 - 1/10/2024 | 125.18% |
Alpha Metallurgical Resources (AMR) | 7/21/2023 - 1/10/2024 | 121.7% |
Uranium Energy (UEC) | 7/21/2023 - 1/10/2024 | 109.79% |
Compania de Minas Buenaventura SAA ADR (BVN) | 7/21/2023 - 1/10/2024 | 101.64% |
Apellis Pharmaceuticals (APLS) | 7/21/2023 - 1/10/2024 | 99.48% |
United States Steel (X) | 7/21/2023 - 1/10/2024 | 96.47% |
PDD (PDD) | 7/21/2023 - 1/10/2024 | 95.38% |
TAL Education (TAL) | 7/21/2023 - 1/10/2024 | 89.59% |
Crowdstrike (CRWD) | 7/21/2023 - 1/10/2024 | 88.11% |
Immunovant (IMVT) | 7/21/2023 - 1/10/2024 | 87.6% |
Crinetics Pharmaceuticals (CRNX) | 7/21/2023 - 1/10/2024 | 86.88% |
Biohaven Pharmaceutical (BHVN) | 7/21/2023 - 1/10/2024 | 86.15% |
Globalstar, Inc Common Stock (GSAT) | 7/21/2023 - 1/10/2024 | 85.05% |
Vertiv (VRT) | 7/21/2023 - 1/10/2024 | 84.7% |
Celestica (CLS) | 7/21/2023 - 1/10/2024 | 82% |
Flex (FLEX) | 7/21/2023 - 1/10/2024 | 76.53% |